Oral aspirin does not up FIT test sensitivity for ID’ing CRC

(HealthDay)—Administration of a single dose of oral aspirin prior to fecal immunochemical testing does not increase test sensitivity for detecting advanced colorectal neoplasms, according to a study published in the May 7 issue of the Journal of the American Medical Association. Hermann Brenner, M.D., M.P.H., from the German Cancer Research Center in Heidelberg, and colleagues conducted a randomized trial in […]

Continue reading »

Coty Sales Slip 10.4 Percent, But Loss Narrows

Coty Inc. sales continued to slip in its fiscal third quarter, but new chief executive officer Pierre Laubies is creating a plan to hoist them up. "We must capitalize on the solid results of the Luxury and Professional Beauty divisions, and address the weakness of the Consumer Beauty division's performance via shelf productivity, product range simplification and brand investment at […]

Continue reading »

Mother’s Day 2019: Rupali Nayak, mom of child with cerebral palsy, talks about her daughter’s journey to exam success

Mother's Day 2019: Meet Rupali Nayak, mother of Mamata Nayak who was born with cerebral palsy and has now passed her class 10 exam securing 90.4 per cent. We take a look at her inspirational journey as a mother. When Rupali Nayak from Mumbai approached a regular school near her house to get her daughter admitted, they refused because her […]

Continue reading »

Cancer risk tools underused in general practice, research shows

Potentially life-saving cancer risk assessment tools are being widely underused by general practices across the UK, according to new research. A team of experts from the University of Exeter’s Medical School has designed a set of risk assessment tools—which can predict the likelihood of undiagnosed cancer based on patients’ symptoms, test results and other clinical information. Now, new NIHR-funded research […]

Continue reading »

FDA approves treatments for heart failure caused by rare disease

(HealthDay)—Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules have been approved to treat adults with cardiomyopathy caused by transthyretin mediated amyloidosis (ATTR-CM), the U.S. Food and Drug Administration announced today. Recommended dosage is four 20-mg capsules of Vyndaqel once daily or a single 61-mg capsule of Vyndamax once daily, according to the manufacturer. The two drugs, which are the first approved […]

Continue reading »

Researchers advance understanding of atrial fibrillation-related dementia

University of Minnesota Medical School researchers have determined that atrial fibrillation (Afib) is independently associated with changes that occur with aging and dementia. “Atrial Fibrillation and Brain Magnetic Resonance Imaging Abnormalities” published in Stroke advances researchers’ understanding of the mechanisms underlying atrial fibrillation-related dementia. Jeremy Berman, a University of Minnesota cardiology fellow is the first author of this paper. It […]

Continue reading »
1 199 200 201 202 203 387